MUC1 in mesothelioma and the biology of MUC1 on the tumour it self.

- In an ideal world and given more time I would like to continue to work on pathways developed from my thesis looking at designing therapeutic targets for the treatment of malignant mesothelioma.

Mulrennan, S., S. Baltic, S. Aggarwal, J. Wood, A. Miranda, F. Frost, J. Kaye, and P. Thompson. 2015.“The Role of Receptor for Advanced Glycation End Products in Airway Inflammation in CF and CF related Diabetes.”Scientific Reports 5: 1-9.